The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1935, 28: 353-361.
Copyright © 1935 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brodie, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Brodie, M.

The Rôle of Convalescent Serum in Preparalytic Poliomyelitis

Maurice Brodie1

From the Department of Bacteriology, New York University and Bellevue Hospital Medical School and Bureau of Laboratories, Department of Health, New York

Abstract

1. The pathogenesis of poliomyelitis, as a disease transmitted by nerve fibers and entirely neurotropic, suggests the ineffectiveness of serum therapy.
2. Additional experimental data concerning the use of large quantities of serum, or whole blood, in the various stages of the disease, give further evidence to its lack of value.
3. Therefore, in serum therapy one is faced with two possibilities:
a. Antibody can never reach the virus in the central nervous system.
b. Still larger amounts must be used, e.g., hyperimmune horse serum, but from the data herewith given the likelihood of success with such a serum is slight.

Footnotes

1 National Research Fellow. This work was supported by grants from The Rockefeller Foundation and New York Foundation.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1935 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1935 by The American Association of Immunologists, Inc. All rights reserved.